A Comparative Study Between Anterior Glenoid Block With Sub-omohyoid Suprascapular Block Versus Interscalene Block in Shoulder Arthroscopy

NCT ID: NCT06609590

Last Updated: 2025-07-28

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

60 participants

Study Classification

INTERVENTIONAL

Study Start Date

2024-09-25

Study Completion Date

2025-03-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The patients will be randomized into 2 equal groups by a computer-generated random numbers table, named group A, B.

Group A: Patients will receive Anterior glenoid block combined with suprascapular nerve block.

Group B: Patients will receive conventional interscalene block.

In group A, the patient will be supine for anterior glenoid block.

The suprascapular nerve will be identified as it branch off from the superior trunk and will be traced until it courses beneath the inferior belly of the omohyoid muscle.

In group B, interscalene brachial plexus block will be performed.

The primary outcomes will be as follows: (1) 11-point (0-10) numeric rating scale (NRS) pain score immediately before surgery starts and after surgery; (2) degree of preserved diaphragmatic function (DPDF): the ratio of postoperative to pre-block (baseline) diaphragmatic excursion amplitude will be assessed in the holding area using a curvilinear probe (Sono Site, Transportable fuji M-turbo ultrasound system).;(3) degree of preserved handgrip strength (DPHS): the ratio of postoperative to pre-block (baseline) handgrip strength (the maximal force patients exerted when instructed to squeeze the dynamometer handles as tightly as feasible). Measurements will be done before surgery, immediately postoperative, 4, 8, and 24 hours postoperatively.

And (4) Recording of the complications which are: Hematoma, nerve injury, allergy to any of the used drugs.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Shoulder Pain

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

TRIPLE

Participants Caregivers Investigators

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Group A

Patients will receive Anterior glenoid block combined with suprascapular nerve block.

Group Type EXPERIMENTAL

Glenoid nerve block combined with Sub-omohyoid Anterior Suprascapular nerve Block

Intervention Type PROCEDURE

Ultrasound guided anterior glenoid nerve block combined with Sub-omohyoid Anterior Suprascapular nerve Block

Group B

The patients will Interscalene brachial plexus block.

Group Type EXPERIMENTAL

Interscalene brachial plexus block

Intervention Type PROCEDURE

Ultrasound guided interscalene brachial plexus block

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Glenoid nerve block combined with Sub-omohyoid Anterior Suprascapular nerve Block

Ultrasound guided anterior glenoid nerve block combined with Sub-omohyoid Anterior Suprascapular nerve Block

Intervention Type PROCEDURE

Interscalene brachial plexus block

Ultrasound guided interscalene brachial plexus block

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. Patients American Society of anesthesiologists' physical status (ASA) I to II.
2. Aged 18 to 65 years.
3. Both sexes.
4. Patients scheduled for shoulder arthroscopy.

Exclusion Criteria

1. Patient refusal
2. ASA physical status III or more.
3. Patients with known allergy to any of the study drugs.
4. Infection at the site of injection.
5. Patients with history of cardiovascular disease.
6. Patients with renal disease.
7. Patients with hepatic disease.
8. Patients with neuromuscular disease.
9. Presence of any coagulopathy.
10. Chronic opioid, gabapentin or pregabalin use.
11. Patients with history of any psychiatric disorder.
Minimum Eligible Age

18 Years

Maximum Eligible Age

65 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Ain Shams University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

riham fathy galal

Lecturer

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Ain shams university hospitals

Cairo, , Egypt

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Egypt

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

FAMSU R143/2024

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Scapular Mobilization Versus Capsular Stretch
NCT06705426 NOT_YET_RECRUITING NA